DGAP-News: Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract Eckert & Ziegler Affiliate Receives Further NIAID Funding for Clinical Development 21.07.2022 / 09:00 The issuer is solely responsible for the content of this announcement. Berlin, 21 July 2022. Myelo The...

Related Keywords

Germany ,Hamburg ,Munich ,Bayern ,Berlin ,Frankfurt ,Brandenburg ,Karolin Riehle ,Eckert Ziegler Strahlen ,Eckert Ziegler ,Tradegate Exchange ,National Institutes Of Health ,Funding For Clinical Development ,News Service ,Us National Institute Of Allergy ,Distribution Services ,Clinical Development ,Therapeutics Gmbh ,Infectious Diseases ,National Institutes ,Myelo Therapeutics ,Hematopoietic Acute Radiation Syndrome ,Acute Radiation Syndrome ,Myelo Therapeutics Gmbh ,Radiation Induced Myelosuppression ,Corporate News ,Regulatory Announcements ,Prime Standard ,Regulated Unofficial Market ,Bag ,Key ,Contract ,Heckert ,Ziegler ,Affiliate ,Eceives ,Urther ,Siaid ,Funding ,Linical ,Development ,The ,July ,He ,